IFNG and rheumatoid arthritis: Cell therapy treatment of arthritic mice with INF-γR−/− MSCs had no therapeutic effects on CIA progression suggesting that the therapeutic efficacy of MSCs on RA is highly dependent on the IFN-γ levels and that blockade of IFN-γ signaling on MSCs successfully undermined their immunomodulatory effects.